CN Patent
CN102656173A — 布鲁顿酪氨酸激酶抑制剂
Assigned to Pharmacyclics LLC · Expires 2012-09-05 · 14y expired
What this patent protects
本文描述了激酶抑制剂化合物、此类抑制剂的合成方法和在疾病的治疗中使用此类抑制剂的方法。本文进一步描述了用于测定包括激酶在内的蛋白质的适当抑制剂的方法、试验和系统。
USPTO Abstract
本文描述了激酶抑制剂化合物、此类抑制剂的合成方法和在疾病的治疗中使用此类抑制剂的方法。本文进一步描述了用于测定包括激酶在内的蛋白质的适当抑制剂的方法、试验和系统。
Drugs covered by this patent
- Brukinsa (ZANUBRUTINIB) · BeiGene
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.